Litcius/Paper detail

Camellia oil lowering blood pressure in spontaneously hypertension rats

Li‐Na Guo, Yiting Guo, Ping Wu, Feng Lü, Junsong Zhu, Haile Ma, Yong Chen, Tao Zhang

2020Journal of Functional Foods44 citationsDOIOpen Access PDF

Abstract

The purpose of this study was to investigate the antihypertensive effect of camellia oil in vivo and its potential ACE-pathway mechanism. The results showed that the contents of oleic acid and linoleic acid in camellia oil were 78.83% and 8.32%, respectively. In vivo experimental results exhibited that both low-dose and high-dose groups significantly reduced the systolic blood pressure (SBP) in acute and long-term administration experiments compared to the control group. Camellia oil with various dosages significantly reduced the angiotensin-converting enzyme (ACE) activities of tissues and the levels of endothelin, renin and angiotensin II in serum. Moreover, camellia oil performed a similar reduction level on SBP of spontaneously hypertension rats (SHRs) for both captopril and olive oil. Overall, camellia oil exert antihypertension effect by modulating the balance of endothelium-derived vasoconstrictor and relaxing factors in serum.

Topics & Concepts

CaptoprilCamelliaBlood pressureIn vivoOleic acidPharmacologyChemistryDoseRenin–angiotensin systemCamellia oleiferaInternal medicineEndocrinologyMedicineBiochemistryBotanyBiologyBiotechnologyEdible Oils Quality and AnalysisFatty Acid Research and HealthCholesterol and Lipid Metabolism
Camellia oil lowering blood pressure in spontaneously hypertension rats | Litcius